Classification of anaphylaxis and utility of the EAACI Taskforce position paper on anaphylaxis in children

Mirja Vetander1, Daiva Helander, Charlotta Lindquist

  • 1Department of Paediatrics, Sachs' Children's Hospital, Södersjukhuset, Stockholm, Sweden. mirja.vetander@ki.se

Insights

Accurate anaphylaxis classification is crucial for children. A modified European Academy of Allergy and Clinical Immunology (EAACI) system, incorporating specific respiratory and neurological signs, improved the diagnosis of food-induced anaphylaxis in Swedish pediatric emergency departments.

Area of Science:

  • Pediatric Allergy and Immunology
  • Emergency Medicine
  • Clinical Classification Systems

Background:

  • Anaphylaxis management requires accurate classification and grading of severity.
  • Existing classification tools, such as the European Academy of Allergy and Clinical Immunology (EAACI) guidelines, may have limitations in specific populations.
  • Food-induced anaphylaxis is a common emergency presentation in children.

Purpose of the Study:

  • To evaluate the applicability of the EAACI Taskforce position paper on Anaphylaxis in Children for classifying food-induced anaphylaxis in a Swedish pediatric emergency department cohort.
  • To identify limitations in the EAACI classification for accurately diagnosing and grading anaphylaxis in children.
  • To propose modifications to the EAACI classification to improve its utility for Swedish children.

Main Methods:

  • Retrospective analysis of 381 emergency department visits for food reactions in 371 children at three Stockholm pediatric hospitals in 2007.
  • Comparison of recorded symptoms and signs with the EAACI Taskforce position paper criteria.
  • Modification of the EAACI classification to include additional respiratory, neurological, and cardiovascular signs and symptoms.

Main Results:

  • The original EAACI classification was insufficient for accurate anaphylaxis diagnosis in 65% of cases.
  • After modification, 128 children (35%) were classified with anaphylaxis.
  • Seventy children (19%) did not meet modified criteria but received adrenaline, potentially preventing anaphylaxis; 173 (47%) had neither anaphylaxis nor adrenaline administration.
  • Several severe signs (respiratory, neurological, cardiovascular) were not adequately described in the original EAACI paper, hindering classification.

Conclusions:

  • The EAACI classification tool is valuable but requires adaptation for specific populations, particularly for Swedish children.
  • Incorporating detailed descriptions of respiratory, neurological, and cardiovascular signs is essential for accurate anaphylaxis classification and severity grading.
  • Modified classification systems enhance the diagnosis of food-induced anaphylaxis in pediatric emergency settings.

Related Concept Videos

Allergic Reactions: Anaphylaxis01:30

Allergic Reactions: Anaphylaxis

Anaphylaxis is a severe, life-threatening hypersensitivity reaction mediated by Immunoglobulin E (IgE) antibodies. When IgE binds to allergens, it triggers the release of mediators– histamine, leukotrienes, and prostaglandins from mast cells and basophils. These mediators cause vasodilation, edema, and inflammation, leading to various symptoms.The primary allergens causing anaphylaxis include food items (e.g., peanuts, shellfish), drugs (e.g., penicillin, asparaginase, corticotropin, heparin),...
Allergic Reactions02:06

Allergic Reactions

Overview
Adrenergic Agonists: Therapeutic Uses01:30

Adrenergic Agonists: Therapeutic Uses

Adrenergic agonists have diverse therapeutic uses across various medical conditions and emergencies.
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and anaphylaxis:...
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes: